D An Evelyn has filed 3 insider transactions across 2 companies since May 2024.
Most recent transaction: a grant/award of 25210 shares of Backblaze, Inc. ($BLZE) on May 27, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2025 | Backblaze, Inc. | $BLZE | D An Evelyn | Director | A | Class A Common Stock | 25210 | $0.00 | 99,001.0000 | 54,300,000 | 34.16% | 0.05% |
| April 30, 2025 | Matinas BioPharma Holdings, Inc. | $MTNB | D An Evelyn | Director | A | Stock Option (right to Buy) | 11600 | $0.00 | 11,600.0000 | 5,086,985 | 9999.99% | 0.23% |
| May 16, 2024 | Backblaze, Inc. | $BLZE | D An Evelyn | Director | A | Class A Common Stock | 20604 | $0.00 | 73,791.0000 | 0 | 38.74% | 0.00% |